Abris Acquires Polish Health Care Network Operator Scanmed

Abris Capital Partners, through its Abris CEE Mid-Market III fund, has acquired 100% of Poland-based health care network operator Scanmed from Life Healthcare Group for an undisclosed amount. The transaction is subject to regulatory approvals and is expected to close in Q1 2021. Read more… Read More

Matrix and Efung Lead USD135m Series E for Chinese Drug Developer Biostar

Matrix Partners China and Efung Capital led a CNY890m (approximately USD135m) Series E for Beijing Biostar Technologies, a China-based developer of anti-tumor, small-molecule chemical drugs, with participation from CCB International Capital, Sinopharma-CICC Capital, Tianjin Venture Capital Management, and Chengdu Tianfu International Bio-Town Investment & Development. Read more… Read More



(default archive template)